Bullish Moving Averages
12
Bearish Moving Averages
4
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
26148.80Today’s High
26645.2052W low
20605.0052W High
29639.00Open Price
26369.20Prev. Close
28308.1000Volume
14340.00Value
379236357.00Fundamentals
Market Cap Cr
56196.00
Price to Earnings
49.10
Price to Book Value
17.60
Dividend Yield
1.20
PE to Growth
2.10
Op Revenue TTM Cr
5753.36
Net Profit TTM Cr
1145.58
Cash From Operating Activity Cr
893.39
Return on Equity %
29.77
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
30 Apr, 2024
55.5
Week
51.3
Month
52.9
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
26413.35
PIVOT
First Resistance
26677.95
Second Resistance
26909.85
Third Resistance
27174.45
First Support
26181.45
Second Support
25916.85
Third Support
25684.95
Relative Strength Index
48.64
Money Flow Index
27.09
MACD
-344.28
MACD Signal
-388.9
Average True Range
559.77
Average Directional Index
23.03
Rate of Change (21)
-0.99
Rate of Change (125)
16.65
Commodity Channel Index
1.1
Williams %R
-40
BETA
1 Month
0.93
3 Month
0.73
1 Year
0.27
3 Year
0.09
PRICE CHANGE ANALYSIS
↑ 2.8%
1 Week
Low
High
25200
26645.25
↓ -2.49%
1 Month
Low
High
25200
27700
↑ 2.08%
3 Months
Low
High
25200
29638.95
↑ 17.99%
6 Months
Low
High
22000
29638.95
↑ 18.61%
1 Year
Low
High
20605.05
29638.95
| Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 1492.75 | 1549.65 | 1535.00 | 1392.72 | 1366.42 | 1413.01 | 1330.73 | 1276.07 | 1243.10 | 1240.27 | 1237.04 | |
| Operating Expenses Qtr | 1049.45 | 1113.26 | 1124.00 | 1062.96 | 1009.99 | 1036.18 | 1033.97 | 961.20 | 955.30 | 962.37 | 952.68 | |
| Operating Profit Qtr | 387.69 | 380.88 | 355.00 | 280.12 | 316.49 | 343.30 | 270.40 | 293.82 | 269.06 | 259.69 | 265.15 | |
| EBIDT Qtr Cr | 443.30 | 436.39 | 411.00 | 329.76 | 356.43 | 376.83 | 296.76 | 314.87 | 287.80 | 277.90 | 284.36 | |
| Depreciation Qtr | 17.97 | 17.84 | 17.17 | 17.34 | 17.81 | 17.47 | 17.35 | 17.43 | 16.74 | 16.20 | 15.73 | |
| Net Profit Qtr | 310.98 | 312.94 | 290.24 | 231.42 | 246.83 | 265.52 | 205.64 | 211.41 | 199.20 | 192.33 | 195.76 | |
| Basic EPS Qtr | 146.34 | 147.27 | 136.58 | 108.90 | 116.16 | 124.95 | 96.77 | 99.49 | 93.74 | 90.51 | 92.12 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 5502.88 | 4996.48 | 4390.92 | 4207.53 | 3791.89 | |
| Operating Expenses Annual Cr | 4143.10 | 3831.55 | 3388.56 | 3336.70 | 3073.87 | |
| Operating Profit Annual | 1205.63 | 1087.72 | 921.46 | 756.45 | 604.74 | |
| Operating Profit Margin Annual % | 21.91 | 21.77 | 20.99 | 17.98 | 15.95 | |
| Total Expenses Annual Cr | 4229.06 | 3916.75 | 3464.97 | 3404.84 | 3093.03 | |
| EBIDT Annual Cr | 1359.78 | 1164.93 | 1002.36 | 870.83 | 718.02 | |
| EBIDT Annual margin % | 24.71 | 23.32 | 22.83 | 20.70 | 18.94 | |
| Depreciation | 69.97 | 66.10 | 58.13 | 59.61 | 16.92 | |
| PAT Before ExtraOrdinary Items Annual Cr | 949.41 | 798.70 | 690.69 | 592.93 | 450.33 | |
| Net Profit Annual | 949.41 | 798.70 | 690.69 | 592.93 | 450.33 | |
| Basic EPS Annual | 446.78 | 375.86 | 325.04 | 279.04 | 211.93 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 3188.54 | 2819.79 | 2602.16 | 2431.71 | 2008.59 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 160.95 | 201.14 | 207.43 | 224.04 | 75.43 | |
| Total Current Liabilities Annual Cr | 1206.02 | 1203.19 | 1030.86 | 891.10 | 856.89 | |
| Total Capital Plus Liabilities Annual Cr | 4555.51 | 4224.12 | 3840.45 | 3546.85 | 2940.91 | |
| Fixed Assets Annual | 240.57 | 271.66 | 251.44 | 271.47 | 105.69 | |
| Total Non Current Assets Annual | 1530.40 | 371.08 | 321.93 | 342.21 | 179.93 | |
| Total Current Assets Annual | 3025.11 | 3853.04 | 3518.52 | 3204.64 | 2760.98 | |
| Total Assets Annual | 4555.51 | 4224.12 | 3840.45 | 3546.85 | 2940.91 | |
| Contingent Liabilities plus Commitments Annual Cr | 106.06 | 123.78 | 123.51 | 110.98 | 40.60 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 893.39 | 947.66 | 726.74 | 626.11 | 499.13 | |
| Cash from Investing Activity Annual | -147.71 | -395.84 | -71.82 | -401.19 | -257.00 | |
| Cash from Financing Annual Activity | -638.72 | -637.38 | -581.79 | -216.79 | -142.80 | |
| Net Cash Flow Annual | 106.96 | -85.56 | 73.13 | 8.13 | 99.33 |
| Indicator | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 1500.49 | 1326.96 | 1224.55 | 1144.37 | 945.25 | |
| ROE Annual % | 29.77 | 28.32 | 26.54 | 24.38 | 22.42 | |
| ROCE Annual % | 38.50 | 36.37 | 33.60 | 30.54 | 33.64 | |
| Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBDIT Annual Margin % | 25.42 | 23.68 | 23.25 | 21.27 | 19.51 |
| Indicator | Graph |
|---|---|
| Total Qtr Revenue cr | |
| Operating Expenses Qtr | |
| Operating Profit Qtr | |
| EBIDT Qtr Cr | |
| Depreciation Qtr | |
| Net Profit Qtr | |
| Basic EPS Qtr |
| Indicator | Graph |
|---|---|
| Total Revenue Annual | |
| Operating Expenses Annual Cr | |
| Operating Profit Annual | |
| Operating Profit Margin Annual % | |
| Total Expenses Annual Cr | |
| EBIDT Annual Cr | |
| EBIDT Annual margin % | |
| Depreciation | |
| PAT Before ExtraOrdinary Items Annual Cr | |
| Net Profit Annual | |
| Basic EPS Annual |
| Indicator | Graph |
|---|---|
| Total ShareHolders Funds Annual | |
| Minority Interest Liability Annual Cr | |
| Total Non Current Liabilities Annual Cr | |
| Total Current Liabilities Annual Cr | |
| Total Capital Plus Liabilities Annual Cr | |
| Fixed Assets Annual | |
| Total Non Current Assets Annual | |
| Total Current Assets Annual | |
| Total Assets Annual | |
| Contingent Liabilities plus Commitments Annual Cr |
| Indicator | Graph |
|---|---|
| Cash from Operating Activity Annual | |
| Cash from Investing Activity Annual | |
| Cash from Financing Annual Activity | |
| Net Cash Flow Annual |
| Indicator | Graph |
|---|---|
| Book Value Per Share Annual | |
| ROE Annual % | |
| ROCE Annual % | |
| Total Debt to Total Equity Annual | |
| EBDIT Annual Margin % |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| SBI NIFTY MIDCAP 150 INDEX FUND | 1.88 | 74393489 | - | - |
| CANARA ROBECO MUTUAL FUND | 1.25 | 74393490 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| ABBOTT CAPITAL INDIA LIMITED | 50.44 | 74393484 | 0 | 0 |
| ABBOTT HEALTHCARE PRODUCTS LIMITED | 17.62 | 74393485 | 0 | 0 |
| BRITISH COLLOIDS LIMITED | 6.92 | 74393486 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| SBI NIFTY MIDCAP 150 INDEX FUND | 1.88 | 74393489 |
| CANARA ROBECO MUTUAL FUND | 1.25 | 74393490 |
| Name | Holding Percent | Holding Id |
|---|
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Jul 21, 2023 | 145 | SPECIAL | Jul 21, 2023 | Equity Share |
| Jul 21, 2023 | 180 | FINAL | Jul 21, 2023 | Equity Share |
| Aug 02, 2022 | 130 | SPECIAL | - | Equity Share |
| Aug 02, 2022 | 145 | FINAL | - | Equity Share |
| Jul 19, 2021 | 155 | SPECIAL | - | Equity Share |
| Jul 19, 2021 | 120 | FINAL | - | Equity Share |
| Aug 28, 2020 | 143 | SPECIAL | - | Equity Share |
| Aug 28, 2020 | 107 | FINAL | - | Equity Share |
| Aug 13, 2019 | 15 | SPECIAL | - | Equity Share |
| Aug 13, 2019 | 50 | FINAL | - | Equity Share |
| Jul 10, 2018 | 5 | SPECIAL | - | Equity Share |
| Jul 10, 2018 | 50 | FINAL | - | Equity Share |
| Jul 10, 2017 | 40 | FINAL | - | Equity Share |
| Jul 08, 2016 | 35 | FINAL | - | Equity Share |
| Jul 22, 2015 | 31 | FINAL | - | Equity Share |
| Jul 23, 2014 | 23 | FINAL | - | Equity Share |
| Apr 16, 2013 | 17 | FINAL | - | Equity Share |
| May 04, 2012 | 17 | FINAL | - | Equity Share |
| Apr 19, 2011 | 17 | FINAL | - | Equity Share |
| Mar 03, 2010 | 17 | FINAL | - | Equity Share |
| Mar 09, 2009 | 14 | FINAL | - | Equity Share |
| Mar 28, 2008 | 17.5 | FINAL | - | Equity Share |
| Apr 05, 2007 | 17.5 | FINAL | - | Equity Share |
| Apr 21, 2006 | 17.5 | FINAL | - | Equity Share |
| Apr 15, 2005 | 35 | FINAL | - | Equity Share |
| Apr 16, 2004 | 35 | FINAL | - | Equity Share |
| Apr 09, 2003 | 12 | FINAL | - | Equity Share |
| Apr 08, 2002 | - | FINAL | - | Equity Share |
| May 21, 2001 | - | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 09, 2024 | Audited Results & Final Dividend | - |
| Feb 01, 2024 | Quarterly Results | - |
| Nov 09, 2023 | Quarterly Results | - |
| Aug 09, 2023 | Quarterly Results | - |
| May 19, 2023 | Audited Results & Final Dividend | - |
| Feb 10, 2023 | Quarterly Results | - |
| Nov 14, 2022 | Quarterly Results | - |
| Aug 10, 2022 | Quarterly Results | - |
| May 17, 2022 | Audited Results & Dividend | - |
| Feb 09, 2022 | Quarterly Results | - |
| Nov 12, 2021 | Quarterly Results | - |
| Aug 06, 2021 | Quarterly Results | - |
| May 18, 2021 | Audited Results & Final Dividend | - |
| Feb 09, 2021 | Quarterly Results | - |
| Nov 11, 2020 | Quarterly Results | - |
| Aug 07, 2020 | Quarterly Results | - |
| Jun 08, 2020 | Audited Results & Dividend | - |
| Feb 07, 2020 | Quarterly Results | - |
| Nov 12, 2019 | Quarterly Results | - |
| Aug 08, 2019 | Quarterly Results | - |
| May 27, 2019 | Audited Results & Dividend | - |
| Feb 08, 2019 | Quarterly Results | - |
| Nov 13, 2018 | Quarterly Results | - |
| Aug 13, 2018 | Quarterly Results | - |
| May 14, 2018 | Audited Results & Dividend | - |
| Feb 14, 2018 | Quarterly Results | - |
| Nov 13, 2017 | Quarterly Results | - |
| Aug 08, 2017 | Quarterly Results | - |
| May 19, 2017 | Audited Results & Final Dividend | - |
| Feb 06, 2017 | Quarterly Results | - |
| Nov 28, 2016 | Quarterly Results | - |
| Nov 22, 2016 | Resignation of the Company Secretary | - |
| Aug 26, 2016 | Quarterly Results | - |
| May 25, 2016 | Audited Results & Final Dividend | Appointment of new Registrar and Share Transfer Agent. |
| Feb 01, 2016 | Quarterly Results | - |
| Nov 06, 2015 | Quarterly Results | - |
| Aug 12, 2015 | Quarterly Results | - |
| May 27, 2015 | Audited Results & Final Dividend | - |
| Feb 10, 2015 | Quarterly Results | - |
| Nov 11, 2014 | Quarterly Results | - |
| May 28, 2014 | Audited Results & Final Dividend | Revised from 27/05/2014 |
| Feb 08, 2014 | Quarterly Results | - |
| Aug 14, 2013 | Quarterly Results | - |
| Jun 03, 2013 | Others | To consider the sale and transfer of, or other appropriate restructuring of, the proprietary pharmaceuticals dIvision ("PPD") of the Company. |
| Apr 25, 2013 | Quarterly Results | - |
| Feb 20, 2013 | Audited Results & Final Dividend | - |
| Nov 10, 2012 | Quarterly Results | - |
| Aug 03, 2012 | Quarterly Results | - |
| May 14, 2012 | Quarterly Results | - |
| Mar 15, 2012 | Appointment / Resignation of M.D | The Board has appointed Mr. Rehan Khan as Managing Director of the Company w.e.f May 15, 2012 & accepted the resignation of Mr. Vivek Mohan as Managing Director of the Company w.e.f May 15, 2012. |
| Feb 28, 2012 | Audited Results & Final Dividend | The Board has recommended a Final Dividend of Rs. 17.00 per Equity Share of the face value Rs. 10 on 2,12,49,302 Equity Shares of the Company. |
| Nov 01, 2011 | Quarterly Results | - |
| Aug 11, 2011 | Quarterly Results | - |
| Apr 27, 2011 | Quarterly Results | - |
| Feb 28, 2011 | Audited Results & Final Dividend | - |
| Dec 21, 2010 | Quarterly Results | - |
| Nov 24, 2010 | To consider a proposal for Merger | To consider a proposal for Merger of Solvay Pharma India Ltd. with the Company in terms of the provisions of Sections 391 to 394 of the Companies Act, 1956. |
| Sep 28, 2010 | Quarterly Results | - |
| Jun 29, 2010 | Quarterly Results & Others | To change the accounting year of the Co. from Dec 01 - Nov 30 to the calendar year Jan 01 - Dec 31 therefore, The statutory books of accounts of the Co. prepared for a period of 13 months. |
| Mar 30, 2010 | Quarterly Results | - |
| Feb 01, 2010 | Audited Results & Dividend | - |
| Sep 29, 2009 | Quarterly Results | - |
| Jun 24, 2009 | Quarterly Results | - |
| Mar 30, 2009 | Quarterly Results | - |
| Jan 28, 2009 | Audited Results & Dividend | - |
| Sep 23, 2008 | Quarterly Results | - |
| Jun 20, 2008 | Quarterly Results | - |
| Mar 28, 2008 | Quarterly Results | - |
| Feb 14, 2008 | Audited Results & Dividend | - |
| Sep 30, 2007 | Quarterly Results | (Revised) |
| Sep 05, 2007 | Buy Back of Shares | To consider a proposal for buyback of a portion of fully paid equity shares of the Company at a price to be determined by the Board, which will not exceed Rs 650/- per equity share. |
| Jun 21, 2007 | Quarterly Results | - |
| Feb 08, 2007 | Accounts & Dividend | - |
| Sep 18, 2006 | Quarterly Results | - |
| Aug 25, 2006 | Buy Back of Shares | - |
| Jun 29, 2006 | Quarterly Results | - |
| Mar 31, 2006 | Quarterly Results | - |
| Mar 07, 2006 | Accounts & Dividend | (Revised) |
| Sep 21, 2005 | Quarterly Results | - |
| Jun 28, 2005 | Quarterly Results | - |
| Mar 22, 2005 | Quarterly Results | - |
| Jan 25, 2005 | Accounts & Dividend | - |
| Sep 28, 2004 | Quarterly Results | - |
| Jun 28, 2004 | Quarterly Results | - |
| Mar 24, 2004 | Quarterly Results | - |
| Feb 25, 2004 | Accounts & Dividend | - |
| Oct 24, 2003 | Quarterly Results & Others | Amalgamation of Lenbrook Pharmaceuticals with the Company. |
| Sep 30, 2003 | Quarterly Results | - |
| Jun 18, 2003 | Quarterly Results | - |
| Mar 31, 2003 | Quarterly Results | - |
| Feb 21, 2003 | Dividend & Accounts | - |
| Sep 25, 2002 | Quarterly Results | - |
| Jun 27, 2002 | Quarterly Results | - |
| Mar 27, 2002 | Quarterly Results | - |
| Feb 27, 2002 | Accounts, Dividend(11 months) & Others | Accounts & Dividend(11 months)and buy back of equity shares and Sale of company's undertaking at E-1, MIDC Industrial Area, Jejuri 412303. |
| Oct 23, 2001 | Quarterly Results | - |
| Jul 16, 2001 | Quarterly Results | - |
| Apr 30, 2001 | Quarterly Results | - |
| Feb 22, 2001 | Accounts | - |
| Oct 31, 2000 | Quarterly Results | - |
| Jul 28, 2000 | Quarterly Results | - |
| Apr 27, 2000 | Interim Dividend | - |
| Apr 12, 2000 | Interim Dividend (Revised) | - |
| Mar 10, 2000 | Accounts & Dividend. | - |
| Oct 28, 1999 | Quarterly Results | - |
| Jul 27, 1999 | Quarterly Results | - |
| Jul 26, 1999 | Quarterly Results (Revised) | - |
| Apr 28, 1999 | Quarterly Results | - |
| Feb 23, 1999 | Accounts & Dividend | - |
| Oct 07, 1998 | Quarterly Results | - |
| May 06, 1998 | Bonus issue | - |
| Mar 30, 1998 | Accounts & Dividend | - |
| Mar 25, 1997 | Accounts & Dividend | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
29 Apr 2024
ABBOTT INDIA LTD. - 500488 - Board Meeting Intimation for Approving The Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2024 And To Recommend Final Dividend For The Year Ended March 31, 2024.
ABBOTT INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2024 ,inter alia, to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2024 and to recommend final dividend for the year ended March 31, 2024.
27 Apr 2024
ABBOTT INDIA LTD. - 500488 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Voting Results and Scrutinizer''s Report for Postal Ballot.
15 Apr 2024
ABBOTT INDIA LTD. - 500488 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyABBOTT INDIA LTD. 2CIN NO.L24239MH1944PLC007330 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Sangeeta Shetty Designation: Company Secretary and Compliance Officer EmailId: investorrelations.india@abbott.com Name of the Chief Financial Officer: Sridhar Kadangode Designation: Chief Financial Officer EmailId: investorrelations.india@abbott.com Date: 15/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
13 Apr 2024
ABBOTT INDIA LTD. - 500488 - Compliance Certificate Under Reg 40 (9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Compliance Certificate under Reg 40 (9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
12 Apr 2024
ABBOTT INDIA LTD. - 500488 - Announcement under Regulation 30 (LODR)-Change in Management
Appointment of Senior Management Personnel
08 Apr 2024
ABBOTT INDIA LTD. - 500488 - Compliance Certificate For The Year Ended March 31, 2024
Compliance Certificate for the year ended March 31, 2024
08 Apr 2024
ABBOTT INDIA LTD. - 500488 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018.
03 Apr 2024
ABBOTT INDIA LTD. - 500488 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) - Details of Loss of Certificate/Duplicate Certificate
27 Mar 2024
ABBOTT INDIA LTD. - 500488 - Intimation Under Regulation 30
Intimation under Regulation 30
27 Mar 2024
ABBOTT INDIA LTD. - 500488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed, copies of the advertisement published in Business Standard (All Editions in English) and Loksatta (in Marathi) today i.e., Wednesday, March 27, 2024, confirming the dispatch of Postal Ballot Notice through email, process for registration of email addresses and information for remote e-voting.
